학술논문
Prognostic value of EndoPredict test in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trial
Document Type
Article
Author
Penault-Llorca, F.; Mouret-Reynier, M.-A.; Cayre, A.; Dalenc, F.; Chabaud, S.; Bachelot, T.; Cottu, P.; Allouache, D.; Cameron, D.; Grenier, J.; Venat Bouvet, L.; Jegannathen, A.; Campone, M.; Debled, M.; Bonnefoi, H.; Hardy-Bessard, A.-C.; Giacchetti, S.; Barthelemy, P.; Kaluzinski, L.; Mailliez, A.; Legouffe, E.; Martinez, M.; Delbaldo, C.; Mollon-Grange, D.; Macaskill, E.J.; Sephton, M.; Stefani, L.; Belgadi, B.; Winter, M.; Orfeuvre, H.; Lacroix-Triki, M.; Andre, F.; Bliss, J.; Canon, J.-L.; Lemonnier, J.
Source
In: ESMO Open . (ESMO Open, May 2024, 9(5))
Subject
Language
English
ISSN
20597029